Showing results (1-10 of 368) with videos related to
Sort By:
Pageof 37
Contemporary Clinical Trials|November 18, 2006
Cluster-crossover design: a method for limiting clusters level effect in community-intervention studiesJean-Jacques Parienti, Oliver KussClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2025
Background HIV Incidence in PURPOSE 1 and 2 PrEP trialsJean-Jacques ParientiExpert Opinion on Pharmacotherapy|May 31, 2002
Cytokine therapy or structured treatment interruptions in HIV infection: which is best?Jean-Jacques ParientiExpert Opinion on Drug Metabolism & Toxicology|March 23, 2011
Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulationJean-Jacques Parienti, Gilles PeytavinBMC Medical Research Methodology|September 22, 2006
Methodological standards in non-inferiority AIDS trials: moving from adherence to complianceJean-Jacques Parienti, Renaud Verdon, Véronique MassariClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Selected Industry Highlights From IDWeek 2025Jean-Jacques Parienti, Shangxin Shaun Yang, Steven GrinspoonPlos One|March 17, 2016
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-AnalysisPierre Branger, Jean-Jacques Parienti, Maria Pia Sormani, et al.Statistics in Medicine|December 17, 2002
Global goodness-of-fit tests in logistic regression with sparse dataOliver KussJournal of Clinical Epidemiology|August 27, 2013
The z-difference can be used to measure covariate balance in matched propensity score analysesOliver KussClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2009
Better adherence with once-daily antiretroviral regimens: a meta-analysisJean-Jacques Parienti, David R Bangsberg, Renaud Verdon, et al.Pageof 37